{"entity":{"type":"insider","cik":"0001609644","url":"/insider/0001609644","json_url":"/insider/0001609644.json","name":"Sproule Rizwana F","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":47,"n_filings":11,"first":"2015-05-19","last":"2016-03-17","span_basis":"filed_date"},"name_variants":[{"name":"Sproule Rizwana F","source":"filing","n_filings":11,"first_seen":"2015-05-19","last_seen":"2016-03-17"}],"transactions":[{"id":2884406,"accession":"0001209191-16-109315","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-109315","line_url":"/filing/0001209191-16-109315","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001609644","owner_name":"Sproule Rizwana F","owner_display_name":"Sproule Rizwana F","owner_url":"/insider/0001609644","role":"Officer (VP Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (VP Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Regulatory Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":45.26954352941176,"price_display":"45.27","price_state":"stated","total_value":384791.12,"total_display":"384,791.12","total_whole":"384,791","shares_owned_after":10899.0,"shares_owned_after_display":"10,899","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-15","filed_date":"2016-03-17","scope":"insider","n_lines":3},{"id":2987717,"accession":"0001209191-16-100468","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-100468","line_url":"/filing/0001209191-16-100468","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001609644","owner_name":"Sproule Rizwana F","owner_display_name":"Sproule Rizwana F","owner_url":"/insider/0001609644","role":"Officer (VP Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (VP Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Regulatory Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9567.0,"shares_display":"9,567","price_per_share":45.07982544162224,"price_display":"45.08","price_state":"stated","total_value":431278.69,"total_display":"431,278.69","total_whole":"431,279","shares_owned_after":8841.0,"shares_owned_after_display":"8,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-17","filed_date":"2016-02-19","scope":"insider","n_lines":2},{"id":2233439,"accession":"0001209191-16-092246","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-16-092246","line_url":"/filing/0001209191-16-092246","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001609644","owner_name":"Sproule Rizwana F","owner_display_name":"Sproule Rizwana F","owner_url":"/insider/0001609644","role":"Officer (VP Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (VP Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Regulatory Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2767.0,"shares_display":"2,767","price_per_share":56.10492952656306,"price_display":"56.10","price_state":"stated","total_value":155242.34,"total_display":"155,242.34","total_whole":"155,242","shares_owned_after":8939.0,"shares_owned_after_display":"8,939","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-19","filed_date":"2016-01-19","scope":"insider","n_lines":6},{"id":2233411,"accession":"0001209191-16-092246","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-092246","line_url":"/filing/0001209191-16-092246","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001609644","owner_name":"Sproule Rizwana F","owner_display_name":"Sproule Rizwana F","owner_url":"/insider/0001609644","role":"Officer (VP Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (VP Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Regulatory Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6800.0,"shares_display":"6,800","price_per_share":55.233623529411766,"price_display":"55.23","price_state":"stated","total_value":375588.64,"total_display":"375,588.64","total_whole":"375,589","shares_owned_after":11459.0,"shares_owned_after_display":"11,459","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-15","filed_date":"2016-01-19","scope":"insider","n_lines":5},{"id":8255962,"accession":"0001209191-15-085940","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-085940","line_url":"/filing/0001209191-15-085940","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001609644","owner_name":"Sproule Rizwana F","owner_display_name":"Sproule Rizwana F","owner_url":"/insider/0001609644","role":"Officer (VP Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (VP Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Regulatory Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9567.0,"shares_display":"9,567","price_per_share":63.76020068987143,"price_display":"63.76","price_state":"stated","total_value":609993.84,"total_display":"609,993.84","total_whole":"609,994","shares_owned_after":9135.0,"shares_owned_after_display":"9,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-15","filed_date":"2015-12-17","scope":"insider","n_lines":4},{"id":8190164,"accession":"0001209191-15-081111","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-081111","line_url":"/filing/0001209191-15-081111","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001609644","owner_name":"Sproule Rizwana F","owner_display_name":"Sproule Rizwana F","owner_url":"/insider/0001609644","role":"Officer (VP Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (VP Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Regulatory Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9567.0,"shares_display":"9,567","price_per_share":78.13394167450612,"price_display":"78.13","price_state":"stated","total_value":747507.42,"total_display":"747,507.42","total_whole":"747,507","shares_owned_after":4057.0,"shares_owned_after_display":"4,057","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-16","filed_date":"2015-11-18","scope":"insider","n_lines":5},{"id":8886864,"accession":"0001209191-15-076190","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-076190","line_url":"/filing/0001209191-15-076190","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001609644","owner_name":"Sproule Rizwana F","owner_display_name":"Sproule Rizwana F","owner_url":"/insider/0001609644","role":"Officer (VP Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (VP Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Regulatory Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9567.0,"shares_display":"9,567","price_per_share":62.58290895787603,"price_display":"62.58","price_state":"stated","total_value":598730.69,"total_display":"598,730.69","total_whole":"598,731","shares_owned_after":6294.0,"shares_owned_after_display":"6,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-15","filed_date":"2015-10-19","scope":"insider","n_lines":5},{"id":8496731,"accession":"0001209191-15-071271","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-071271","line_url":"/filing/0001209191-15-071271","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001609644","owner_name":"Sproule Rizwana F","owner_display_name":"Sproule Rizwana F","owner_url":"/insider/0001609644","role":"Officer (VP Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (VP Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Regulatory Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9567.0,"shares_display":"9,567","price_per_share":64.36004181038989,"price_display":"64.36","price_state":"stated","total_value":615732.52,"total_display":"615,732.52","total_whole":"615,733","shares_owned_after":3069.0,"shares_owned_after_display":"3,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-15","filed_date":"2015-09-17","scope":"insider","n_lines":3},{"id":8542155,"accession":"0001209191-15-067003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-067003","line_url":"/filing/0001209191-15-067003","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001609644","owner_name":"Sproule Rizwana F","owner_display_name":"Sproule Rizwana F","owner_url":"/insider/0001609644","role":"Officer (VP Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (VP Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Regulatory Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9567.0,"shares_display":"9,567","price_per_share":60.876662485627676,"price_display":"60.88","price_state":"stated","total_value":582407.03,"total_display":"582,407.03","total_whole":"582,407","shares_owned_after":3160.0,"shares_owned_after_display":"3,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2015-08-19","scope":"insider","n_lines":3},{"id":8603470,"accession":"0001209191-15-061778","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-061778","line_url":"/filing/0001209191-15-061778","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001609644","owner_name":"Sproule Rizwana F","owner_display_name":"Sproule Rizwana F","owner_url":"/insider/0001609644","role":"Officer (VP Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (VP Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Regulatory Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9567.0,"shares_display":"9,567","price_per_share":71.8958963102331,"price_display":"71.90","price_state":"stated","total_value":687828.04,"total_display":"687,828.04","total_whole":"687,828","shares_owned_after":6055.0,"shares_owned_after_display":"6,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-15","filed_date":"2015-07-20","scope":"insider","n_lines":4},{"id":8225175,"accession":"0001209191-15-054390","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-054390","line_url":"/filing/0001209191-15-054390","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001609644","owner_name":"Sproule Rizwana F","owner_display_name":"Sproule Rizwana F","owner_url":"/insider/0001609644","role":"Officer (VP Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (VP Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Regulatory Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9567.0,"shares_display":"9,567","price_per_share":56.984195672624644,"price_display":"56.98","price_state":"stated","total_value":545167.8,"total_display":"545,167.80","total_whole":"545,168","shares_owned_after":1695.0,"shares_owned_after_display":"1,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-17","scope":"insider","n_lines":3},{"id":8295126,"accession":"0001209191-15-044683","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-044683","line_url":"/filing/0001209191-15-044683","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001609644","owner_name":"Sproule Rizwana F","owner_display_name":"Sproule Rizwana F","owner_url":"/insider/0001609644","role":"Officer (VP Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (VP Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Regulatory Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9567.0,"shares_display":"9,567","price_per_share":50.15851677641894,"price_display":"50.16","price_state":"stated","total_value":479866.53,"total_display":"479,866.53","total_whole":"479,867","shares_owned_after":6076.0,"shares_owned_after_display":"6,076","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-15","filed_date":"2015-05-19","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":47,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":47,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":47},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001510580","name":"Kite Pharma, Inc.","url":"/issuer/0001510580","role":"Officer (VP Regulatory Affairs)","n_filings":11,"first_seen":"2015-05-19","last_seen":"2016-03-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001609644","retrieved_at":"2026-08-25T13:28:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}